Patient Guide: INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 64 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06295731
Status: 🟢 Enrolling Now
Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 64 locations across the country.

Top locations include:
  • • Duarte, California
  • • Los Angeles, California
  • • Sacramento, California
  • • And 61 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC - Join Clinical Trial NCTNCT06295731

How to Join This Clinical Trial - NCTNCT06295731

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Head and Neck Squamous Cell Carcinoma (HNSCC). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Head and Neck Squamous Cell Carcinoma (HNSCC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06295731 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 64 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 91204 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95816 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95817 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 92123 - United States

Status: RECRUITING

Clinical Research Site

Santa Monica, California 90403 - United States

Status: RECRUITING

Clinical Research Site

Newark, Delaware 19713 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33169 - United States

Status: RECRUITING

Clinical Research Site

Orange City, Florida 32763 - United States

Status: RECRUITING

Clinical Research Site

Weston, Florida 33331 - United States

Status: RECRUITING

And 54 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Head and Neck Squamous Cell Carcinoma (HNSCC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships